GARDASIL 40 ug/.5mL
Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant · INJECTION, SUSPENSION · Merck Sharp & Dohme LLC
GARDASIL is a injection, suspension containing human papillomavirus quadrivalent (types 6, 11, 16, and 18) vaccine, recombinant at 40 ug/.5mL, taken intramuscular. Manufactured by Merck Sharp & Dohme LLC.
Key Facts
- Brand Name
- GARDASIL
- Generic Name
- Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant
- NDC Code (Product)
0006-4045- Manufacturer
- Merck Sharp & Dohme LLC
- Strength
- 40 ug/.5mL
- Dosage Form
- INJECTION, SUSPENSION
- Route
- INTRAMUSCULAR
- Marketing Status
- Application #
- BLA125126
- Marketing Start
- 06/08/2006
Recall History
No Recall HistoryFrequently Asked Questions
What is GARDASIL used for?
GARDASIL contains Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant. It is a injection, suspension taken intramuscular. Consult your doctor for specific uses.
Is GARDASIL a controlled substance?
GARDASIL is not classified as a controlled substance by the DEA.
What is the generic name for GARDASIL?
The generic name for GARDASIL is Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant. There are no other listed brand versions of Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant.
What is the NDC code for GARDASIL 40 ug/.5mL?
The NDC (National Drug Code) for GARDASIL 40 ug/.5mL is 0006-4045, listed by Merck Sharp & Dohme LLC.
Other GARDASIL Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)